Four Cardinal Health Executives Sold Stock in Quick Succession After Its 58% Run-Up

A wave of insider sales at Cardinal Health surfaced this month. CEO Jason Hollar moved 124,529 shares in two days, divesting 125,000 shares across two sessions. CIO Michelle Greene parted with 11,650 shares, leaving her with 10,330 shares worth $2.43 million. Pharma chief Debbie Weitzman sold 7,354 shares yet still grew her overall stake by 47%, and now holds $18.3 million in direct shares. Legal chief Jessica Mayer also filed a transaction and holds 33,076 shares valued at $7.77 million. All four sales followed a stock run of 57% to 58% over the past year, according to the underlying filings. Insider selling after a large run-up is common and does not necessarily signal a change in view on the company; in several cases here, executives grew their net stakes even while selling some shares to cover taxes or diversify. What is unresolved is whether this cluster of sales, coming from multiple senior executives in a short window, reflects normal portfolio management or a shared read that the stock's rally has run its course. The filings alone do not say.